Elizabeth A. Grosen - Concepedia

Author

Elizabeth A. Grosen

University of California, Irvine

Also Known As

E A Grosen, ELIZABETH A. GROSEN, Elizabeth A Grosen, Elizabeth A. Grosen, Elizabeth Grosen

Publications

681

Citations

H-Index

Concepts

All Affiliations

University of California, Irvine University of California, Irvine Medical Center Texas Oncology Cancer Care Northwest Gradalis (United States)

About

Elizabeth A. Grosen is an author at University of California, Irvine specializing in medicine, ovarian cancer, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	423
2	Obstetrics	5	5	312
3	Immunology	4	4	251
4	Pathology	2	2	51
5	Endocrinology	1	1	46

Elizabeth A. Grosen

Publications

606

Citations

H-Index

Page 1

	Year	Citations
Hormone replacement therapy in breast cancer survivors: A cohort study Philip J. DiSaia, Elizabeth A. Grosen, Tom Kurosaki, American Journal of Obstetrics and Gynecology Breast OncologyEndocrine-related CancerMedicineGynecologyMenopausal Hormone Therapy	1996	112
An individualized intervention to overcome patient-related barriers to pain management in women with gynecologic cancers Sandra E. Ward, Heidi Donovan, Brenda Owen, Research in Nursing & Health	2000	112
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial Rodney P. Rocconi, Elizabeth A. Grosen, Sharad Ghamande, The Lancet Oncology MedicineImmunologyGynecologyImmune Checkpoint InhibitorCancer Treatment	2020	112
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer Jonathan Oh, Minal Barve, Carolyn M. Matthews, Gynecologic Oncology Vigil® DnaMedicineImmunologyPhase Ii StudyImmune Checkpoint Inhibitor	2016	88
Human uterine and ovarian expression of growth hormone–releasing hormone messenger RNA in benign and malignant gynecologic conditions Omid Khorram, Mark A. Garthwaite, Elizabeth A. Grosen, Fertility and Sterility Developmental BiologyGrowth HormoneHuman GrowthUterine ReceptivityHormone Messenger Rna	2001	46
Replacement therapy for breast cancer survivors. A pilot study Philip J. DiSaia, Elizabeth A. Grosen, Franco Odicino, Cancer	1995	32
Measurement of the Soluble Membrane Receptors for Tumor Necrosis Factor and Lymphotoxin in the Sera of Patients with Gynecologic Malignancy Elizabeth A. Grosen, Gale A. Granger, Maki Gatanaga, Gynecologic Oncology InflammationTumor Necrosis FactorSoluble Membrane ReceptorsGynecologic MalignancyImmunology	1993	28
Spontaneous Release of Interleukin-6 by Primary Cultures of Lymphoid and Tumor Cell Populations Purified from Human Ovarian Carcinoma Robert A. Burger, Elizabeth A. Grosen, Gene R. Ioli, Journal of Interferon & Cytokine Research CytokineLymphoid NeoplasiaCancer ImmunosurveillanceHuman Ovarian CarcinomaIl-6 Found	1995	23
An experience with estrogen replacement therapy in breast cancer survivors. Wendy R. Brewster, Philip J. DiSaia, Elizabeth A. Grosen, PubMed	1999	21
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy Robert A. Burger, Kathleen M. Darcy, Philip J. DiSaia, Cancer	2004	18

Page 1